Skip to content
Catalyst

PapersPMID:31136659

Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial.

The American journal of clinical nutrition2019The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceraisesFlow-mediated dilation
  2. Finding, moderate evidenceraisesTriglycerides
Study, every finding
RCT
  • “However, after 6 mo of 1 cup blueberries/d %FMD significantly increased (1 cup: 1.45%; 1/2 cup: 0.00%; placebo: 0.39%; P = 0.003), and AIx significantly reduced, compared with other treatments (1 cup: –2.24%; 1/2 cup: 0.45%; placebo: 0.24%; P = 0.04).”
    Interests
    Industry funded
    Dose studied
    26 g/day freeze-dried blueberry powder (1 cup, 150 g fresh equivalent; 364 mg anthocyanins, 879 mg phenolics) for 6 months versus 26 g isocaloric placebo powder
    Population
    Adults aged 50-75 years with metabolic syndrome; the 1 cup (150 g fresh-equivalent) dose arm only, compared across placebo and 1/2 cup arms, change over 6 months
  • “However, TG levels differed (P = 0.04; Table 2), with a significant increase in the 1/2-cup blueberry group compared with placebo (P = 0.01, Table 2); this remained when analysis was restricted to statin nonusers (P = 0.04; Supplemental Table 6).”
    Interests
    Industry funded
    Dose studied
    13 g freeze-dried blueberry powder plus 13 g placebo material per day (1/2 cup, 75 g fresh equivalent; 182 mg anthocyanins) for 6 months versus 26 g placebo powder
    Population
    Adults aged 50-75 years with metabolic syndrome; the 1/2 cup (75 g fresh-equivalent) dose arm only, compared with placebo over 6 months

Study record

Design
randomised controlled trial
Species
human
Population
Overweight and obese adults aged 50-75 y with metabolic syndrome (3 or more components), UK
Participants
115
Comparator
placebo
Duration
183 days
Endpoints measured
65